- Home
- XENE vs FUL Comparison
XENE vs FUL Comparison
Compare XENE & FUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XENE | FUL |
|---|---|---|
| Founded | 1996 | 1887 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.5B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | XENE | FUL |
|---|---|---|
| Price | $42.28 | $59.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 5 |
| Target Price | $54.09 | ★ $70.20 |
| AVG Volume (30 Days) | ★ 1.1M | 503.8K |
| Earning Date | 02-26-2026 | 01-14-2026 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | N/A | ★ 19.57 |
| EPS | N/A | ★ 2.75 |
| Revenue | $7,500,000.00 | ★ $3,473,589,000.00 |
| Revenue This Year | N/A | $3.15 |
| Revenue Next Year | N/A | $3.01 |
| P/E Ratio | ★ N/A | $21.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $26.74 | $47.56 |
| 52 Week High | $46.60 | $67.05 |
Technical Indicators
Market Signals| Indicator | XENE | FUL |
|---|---|---|
| Relative Strength Index (RSI) | 50.52 | 44.01 |
| Support Level | $40.81 | $57.83 |
| Resistance Level | $43.14 | $60.94 |
| Average True Range (ATR) | 1.90 | 2.07 |
| MACD | 0.09 | -0.53 |
| Stochastic Oscillator | 66.89 | 15.40 |
Price Performance
Historical ComparisonAbout XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
About FUL H. B. Fuller Company
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.